<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Induction therapy for peripheral T cell lymphoma (excluding systemic anaplastic large cell lymphoma)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Induction therapy for peripheral T cell lymphoma (excluding systemic anaplastic large cell lymphoma)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Induction therapy for peripheral T cell lymphoma (excluding systemic anaplastic large cell lymphoma)</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm describes response-guided induction therapy for initial management of PTCL (excluding sALCL) in adults. Refer to related UpToDate material for details of diagnosis, treatment, and response assessment for PTCL. Postinduction management for patients with complete response on end-of-induction PET and management of refractory PTCL are described separately.</div><div class="graphic_footnotes"><p>BV-CHP: brentuximab vedotin, cyclophosphamide, doxorubicin, prednisone; CHOEP: cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone; CHOP: cyclophosphamide, doxorubicin, vincristine, prednisone; PET3: positron emission tomography performed after 3 cycles of induction therapy; PTCL: peripheral T cell lymphoma; sALCL: systemic anaplastic large cell lymphoma.</p>
<p>* CHOEP induction is generally limited to patients &lt;65 years without major organ dysfunction, but eligibility criteria may vary.</p>
Â¶ Based on 5-point (Deauville) score using Lugano criteria.</div><div id="graphicVersion">Graphic 142751 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
